Vaccination against TIE2 reduces atherosclerosis

Atherosclerosis

Volumn 204, Issue 2, 2009, Pages 365-371

  Hauer, Arnaud D ^a   Habets, Kim L L ^a   van Wanrooij, Eva J A ^a   de Vos, Paula ^a   Krueger, Joerg ^b   Reisfeld, Ralph A ^b   van Berkel, Theo J C ^a   Kuiper, Johan ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Angiogenesis; Atherosclerosis; Plaque stability; TIE2; Vaccination

Indexed keywords

ANGIOPOIETIN RECEPTOR; DNA VACCINE; PLASMID DNA; PLASMID PCDNA3 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BACTERIAL STRAIN; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG INHIBITION; DRUG MECHANISM; FLUORESCENCE ACTIVATED CELL SORTING; INTIMA; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM;

ADMINISTRATION, ORAL; ANIMALS; ATHEROSCLEROSIS; COLLAGEN; DISEASE MODELS, ANIMAL; FEMALE; GENETIC VECTORS; IMMUNITY, CELLULAR; IMMUNIZATION SCHEDULE; LEUKOCYTES, MONONUCLEAR; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; RECEPTOR, TIE-2; RECEPTORS, LDL; SALMONELLA TYPHIMURIUM; VACCINES, ATTENUATED; VACCINES, DNA;

EID: 67349273285     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.09.039     Document Type: Article

References (36)

1. Palinski W., Miller E., and Witztum J.L. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci USA 92 (1995) 821-825
2. Fredrikson G.N., Soderberg I., Lindholm M., et al. Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences. Arterioscler Thromb Vasc Biol 23 (2003) 879-884
3. Rittershaus C.W., Miller D.P., Thomas L.J., et al. Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis. Arterioscler Thromb Vasc Biol 20 (2000) 2106-2112
4. Hauer A.D., Uyttenhove C., de Vos P., et al. Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis. Circulation 112 (2005) 1054-1062
5. Silvestre J.S., Gojova A., Brun V., et al. Transplantation of bone marrow-derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition. Circulation 108 (2003) 2839-2842
6. Abedin M., Tintut Y., and Demer L.L. Mesenchymal stem cells and the artery wall. Circ Res 95 (2004) 671-676
7. Hauer A.D., van Puijvelde G.H., Peterse N., et al. Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosis. Arterioscler Thromb Vasc Biol 27 (2007) 2050-2057
8. Niethammer A.G., Xiang R., Becker J.C., et al. A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat Med 8 (2002) 1369-1375
9. Shalaby F., Rossant J., Yamaguchi T.P., et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376 (1995) 62-66
10. Li Y., Wang M.N., Li H., et al. Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis. J Exp Med 195 (2002) 1575-1584
11. Tepper O.M., Capla J.M., Galiano R.D., et al. Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 105 (2005) 1068-1077
12. Dumont D.J., Yamaguchi T.P., Conlon R.A., Rossant J., and Breitman M.L. Tek a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene 7 (1992) 1471-1480
13. Sato T.N., Qin Y., Kozak C.A., and Audus K.L. Tie-1 and Tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc Natl Acad Sci USA 90 (1993) 9355-9358
14. Wong A.L., Haroon Z.A., Werner S., et al. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res 81 (1997) 567-574
15. Sato T.N., Tozawa Y., Deutsch U., et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376 (1995) 70-74
16. Davis S., Aldrich T.H., Jones P.F., et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87 (1996) 1161-1169
17. Teichert-Kuliszewska K., Maisonpierre P.C., Jones N., et al. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc Res 49 (2001) 659-670
18. Hu Y., Davison F., Zhang Z., and Xu Q. Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation 108 (2003) 3122-3127
19. Lemieux C., Maliba R., Favier J., et al. Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. Blood 103 (2004) 3789-3797
20. Iurlaro M., Scatena M., Zhu W.H., et al. Rat aorta-derived mural precursor cells express the Tie2 receptor and respond directly to stimulation by angiopoietins. J Cell Sci 116 (2003) 3635-3643
21. Nowak G., Karrar A., Holmen C., et al. Expression of vascular endothelial growth factor receptor-2 or Tie-2 on peripheral blood cells defines functionally competent cell populations capable of reendothelialization. Circulation 110 (2004) 3699-3707
22. -/- mice. J. Vasc. Biol. 42 Sup: 2 (2005) 56
23. von der Thusen J.H., van Berkel T.J., and Biessen E.A. Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Circulation 103 (2001) 1164-1170
24. Groot P.H., van Vlijmen B.J., Benson G.M., et al. Quantitative assessment of aortic atherosclerosis in APOE*3 Leiden transgenic mice and its relationship to serum cholesterol exposure. Arterioscler Thromb Vasc Biol 16 (1996) 926-933
25. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
26. Reisfeld R.A., Niethammer A.G., Luo Y., and Xiang R. DNA vaccines suppress tumor growth and metastases by the induction of anti-angiogenesis. Immunol Rev 199 (2004) 181-190
27. Moulton K.S., Heller E., Konerding M.A., et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 99 (1999) 1726-1732
28. Moulton K.S., Vakili K., Zurakowski D., et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 100 (2003) 4736-4741
29. Willam C., Koehne P., Jurgensen J.S., et al. Tie2 receptor expression is stimulated by hypoxia and proinflammatory cytokines in human endothelial cells. Circ Res 87 (2000) 370-377
30. Thurston G. Role of angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Cell Tissue Res 314 (2003) 61-68
31. De Palma M., Venneri M.A., Galli R., et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8 (2005) 211-226
32. Torres Filho I.P., Leunig M., Yuan F., Intaglietta M., and Jain R.K. Noninvasive measurement of microvascular and interstitial oxygen profiles in a human tumor in SCID mice. Proc Natl Acad Sci USA 91 (1994) 2081-2085
33. Bhardwaj S., Roy H., Heikura T., and Yla-Herttuala S. VEGF-A VEGF-D and VEGF-D-induced intimal hyperplasia in carotid arteries. Eur J Clin Invest 35 (2005) 669-676
34. Khurana R., Zhuang Z., Bhardwaj S., et al. Angiogenesis-dependent and independent phases of intimal hyperplasia. Circulation 110 (2004) 2436-2443
35. -/- double knockout mice. Arterioscler Thromb Vasc Biol 26 (2006) 347-352 Feb.
36. George J., Afek A., Abashidze A., et al. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 25 (2005) 2636-2641